Related stories
Lifecore Biomedical Reports Higher Q3 Net Loss and Lower Revenue
Lifecore Biomedical reported a higher third-quarter net loss and lower third-quarter revenue.
M impact | EQUITY | Nov 04, 2026, 12:23 PM UTC
SIT Reports Q3 Consolidated Revenue of €75 Million
M impact | EQUITY | Nov 04, 2026, 12:21 PM UTC
HP appoints Emma Walmsley as chief executive
HP appointed former GSK chief executive and Microsoft board member Emma Walmsley as its chief executive.
M impact | EQUITY | Nov 04, 2026, 12:21 PM UTC
REED Sets EUR 130.18 Million Debt-for-Equity Swap Under Restructuring Plan
M impact | EQUITY | Nov 04, 2026, 12:21 PM UTC
Ennature Bio Pharma Lists on NSE and BSE
The company made its market debut on Wednesday, November 4, 2026. For FY26, it reported net revenue of ₹246 crore and EBITDA of ₹29 crore.
M impact | EQUITY | Nov 04, 2026, 12:21 PM UTC
Performance Food Beats Q1 Profit Estimates on Higher Prices and Cases Sold
M impact | EQUITY | Nov 04, 2026, 12:20 PM UTC